ANSL.F Stock Overview
Designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Ansell Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$21.00 |
| 52 Week High | AU$21.00 |
| 52 Week Low | AU$14.60 |
| Beta | 0.46 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | 58.61% |
| 33 Year Change | -7.69% |
| 5 Year Change | 13.51% |
| Change since IPO | 782.35% |
Recent News & Updates
Recent updates
Shareholder Returns
| ANSL.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | 0.2% | -1.3% |
| 1Y | 58.6% | 25.6% | 30.7% |
Return vs Industry: ANSL.F exceeded the US Medical Equipment industry which returned 25.6% over the past year.
Return vs Market: ANSL.F exceeded the US Market which returned 30.7% over the past year.
Price Volatility
| ANSL.F volatility | |
|---|---|
| ANSL.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 15.1% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: ANSL.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine ANSL.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1893 | 15,000 | Neil Salmon | www.ansell.com |
Ansell Limited designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates in two segments, Healthcare and Industrial. The Healthcare segment manufactures and markets solutions comprising surgical gloves, single use and examination gloves, and clean and sterile gloves and garments, as well as consumables for hospitals, surgical centers, dental surgeries, veterinary clinics, first responders, manufacturers, auto repair shops, chemical plants, laboratories, and life sciences and pharmaceutical companies.
Ansell Limited Fundamentals Summary
| ANSL.F fundamental statistics | |
|---|---|
| Market cap | US$2.93b |
| Earnings (TTM) | US$76.50m |
| Revenue (TTM) | US$1.62b |
38.3x
P/E Ratio1.8x
P/S RatioIs ANSL.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ANSL.F income statement (TTM) | |
|---|---|
| Revenue | US$1.62b |
| Cost of Revenue | US$994.50m |
| Gross Profit | US$624.80m |
| Other Expenses | US$548.30m |
| Earnings | US$76.50m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 11, 2025
| Earnings per share (EPS) | 0.53 |
| Gross Margin | 38.58% |
| Net Profit Margin | 4.72% |
| Debt/Equity Ratio | 40.1% |
How did ANSL.F perform over the long term?
See historical performance and comparison